The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
GABAA Receptor Channel Pharmacology
Abstract
GABA(A) receptor channels are ubiquitous in the mammalian central nervous system mediating fast inhibitory neurotransmission by becoming permeant to chloride ions in response to GABA. The emphasis of this review is on the rich chemical diversity of ligands that influence GABA(A) receptor function. Such diversity provides many avenues for the design and development of new chemical entities acting on GABA(A) receptors. There is also a significant diversity of GABA(A) receptor subtypes composed of different protein subunits. The discovery of subtype specific agents is a major challenge in the continuing development of GABA(A) receptor pharmacology. Leads for the discovery of new chemical entities that influence GABA(A) receptors come from using recombinant GABA(A) receptors of known subunit composition as has been elegantly demonstrated by the refining of benzodiazepine actions with alpha1 subunit preferring agents showing sedative properties but not anxiolytic properties. The most recent advances in the therapeutic use of agents acting on GABA(A) receptors concern the promotion of sound sleep. Many herbal medicines are used to promote sleep and many of their active ingredients include flavonoids and terpenoids known to modulate GABA(A) receptor function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Jorge-Rivera, J. C., McIntyre, K. L., & Henderson, L. P. (2000) · Journal of Neurophysiology · doi:10.1152/jn.2000.83.6.3299 · Cited by 53
RetractedFlavonoid antioxidants: chemistry, metabolism and structure-activity relationships
Heim, K. E., Tagliaferro, A. R., & Bobilya, D. J. (2002) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(02)00208-5 · Cited by 4,207
The biochemistry and medical significance of the flavonoids
Havsteen, B. H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00298-x · Cited by 2,672
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225
Structure and gating mechanism of the acetylcholine receptor pore
Miyazawa, A., Fujiyoshi, Y., & Unwin, N. (2003) · Nature · doi:10.1038/nature01748 · Cited by 1,270
Which GABAA-receptor subtypes really occur in the brain?
McKernan, R. M., & Whiting, P. J. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)80023-3 · Cited by 1,222
Barnard, E. A., Skolnick, P., Olsen, R. W., Möhler, H., Sieghart, W., Biggio, G., Bræstrup, C., Bateson, A. N., & Langer, S. Z. (1998) · PubMed · Cited by 1,204
Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H. (1999) · Nature · doi:10.1038/44579 · Cited by 1,172
Metabolism and functions of gamma-aminobutyric acid
Shelp, B. (1999) · Trends in Plant Science · doi:10.1016/s1360-1385(99)01486-7 · Cited by 965
Purdy, R. H., Morrow, A. L., Moore, P. H., & Paul, S. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4553 · Cited by 951
Molecular and neuronal substrate for the selective attenuation of anxiety
Löw, K., Crestani, F., Keist, R., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Rülicke, T., Bluethmann, H., Möhler, H., et al. (2000) · Science · doi:10.1126/science.290.5489.131 · Cited by 946
McKernan, R. M., Rosahl, T. W., Reynolds, D. S., Sur, C., Wafford, K. A., Atack, J. R., Farrar, S., Myers, J., Cook, G., Ferris, P., et al. (2000) · Nature Neuroscience · doi:10.1038/75761 · Cited by 944
Dietary flavonols: chemistry, food content, and metabolism
Aherne, S. A., & O’Brien, N. M. (2002) · Nutrition · doi:10.1016/s0899-9007(01)00695-5 · Cited by 838
Mutant GABAA receptor γ2-subunit in childhood absence epilepsy and febrile seizures
Wallace, R. H., Marini, C., Petrou, S., Harkin, L. A., Bowser, D. N., Panchal, R. G., Williams, D. A., Sutherland, G. R., Mulley, J. C., Scheffer, I. E., et al. (2001) · Nature Genetics · doi:10.1038/ng0501-49 · Cited by 781
First genetic evidence of GABAA receptor dysfunction in epilepsy: a mutation in the γ2-subunit gene
Baulac, S., Huberfeld, G., Gourfinkel-An, I., Mitropoulou, G., Beranger, A., Prud'homme, J.-F., Baulac, M., Brice, A., Bruzzone, R., & LeGuern, E. (2001) · Nature Genetics · doi:10.1038/ng0501-46 · Cited by 766
A new benzodiazepine pharmacology
Möhler, H., Fritschy, J. M., & Rudolph, U. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.2 · Cited by 716 · cited 1×
“There are many reviews on aspects GABAA receptors including methodological approaches to the study of GABAA receptors [10, 11], GABAA receptor subtypes [7, 12-15], neurosteroid modulation [16, 17], drug interactions [18], specific agonists and partial agonists [19], receptor recycling and regulation [20], novel modula…”
BackgroundAllosteric binding sites on cell-surface receptors: novel targets for drug discovery
Christopoulos, A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd746 · Cited by 664
Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy
Cossette, P., Liu, L., Brisebois, K., Dong, H., Lortie, A., Vanasse, M., Saint-Hilaire, J.-M., Carmant, L., Verner, A., Lu, W.-Y., et al. (2002) · Nature Genetics · doi:10.1038/ng885 · Cited by 655
Collinson, N., Kuenzi, F. M., Jarolimek, W., Maubach, K. A., Cothliff, R., Sur, C., Smith, A., Otu, F. M., Howell, O., Atack, J. R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-13-05572.2002 · Cited by 628 · cited 1×
“Mice lacking the α5 gene show improved performance in the Morris water maze model of spatial learning, whereas the performance in nonhippocampal-dependent learning and in anxiety tasks were unaltered in comparison with wild-type controls [73].”
ResultBormann, J. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01413-3 · Cited by 628
Pharmacological characterization of a novel cell line expressing human α4β3δ GABAA receptors
Brown, N., Kerby, J., Bonnert, T. P., Whiting, P. J., & Wafford, K. A. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704795 · Cited by 603
Cancer preventive effects of flavonoids—a review
Le Marchand, L. (2002) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(02)00186-5 · Cited by 583
Caraiscos, V. B., Elliott, E. M., You-Ten, K. E., Cheng, V. Y., Belelli, D., Newell, J. G., Jackson, M. F., Lambert, J. J., Rosahl, T. W., Wafford, K. A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307231101 · Cited by 571
Mihalek, R. M., Banerjee, P. K., Korpi, E. R., Quinlan, J. J., Firestone, L. L., Mi, Z.-P., Lagenaur, C., Tretter, V., Sieghart, W., Anagnostaras, S. G., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12905 · Cited by 520
Rudolph, U., & Möhler, H. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121429 · Cited by 519
Priestley, C. M., Williamson, E. M., Wafford, K. A., & Sattelle, D. B. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705542 · Cited by 501
Modulation of the GABA receptor complex by a steroid anaesthetic
Harrison, N. L., & Simmonds, M. A. (1984) · Brain Research · doi:10.1016/0006-8993(84)90299-3 · Cited by 499
Neurosteroid modulation of GABAA receptors
Lambert, J. J., Belelli, D., Peden, D. R., Vardy, A. W., & Peters, J. A. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.09.001 · Cited by 493
Drug interactions at GABAA receptors
Korpi, E. R., Gründer, G., & Lüddens, H. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00013-8 · Cited by 473
GABAA receptor subtypes: dissecting their pharmacological functions
Rudolph, U., Crestani, F., & Möhler, H. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01646-1 · Cited by 471
Homanics, G. E., DeLorey, T. M., Firestone, L. L., Quinlan, J. J., Handforth, A., Harrison, N. L., Krasowski, M. D., Rick, C. E. M., Korpi, E. R., Mäkelä, R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4143 · Cited by 469
Wallner, M., Hanchar, H. J., & Olsen, R. W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2435171100 · Cited by 462
Gottesmann, C. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00034-9 · Cited by 439
Enhanced Neurosteroid Potentiation of Ternary GABAAReceptors Containing the δ Subunit
Wohlfarth, K. M., Bianchi, M. T., & Macdonald, R. L. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01541.2002 · Cited by 393
Perry, N. B., Anderson, R. E., Brennan, N. J., Douglas, M. H., Heaney, A. J., McGimpsey, J. A., & Smallfield, B. M. (1999) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf981170m · Cited by 377
Viola, H., Wasowski, C., Levi de Stein, M., Wolfman, C., Silveira, R., Dajas, F., Medina, J., & Paladini, A. (1995) · Planta Medica · doi:10.1055/s-2006-958058 · Cited by 365
Höld, K. M., Sirisoma, N. S., Ikeda, T., Narahashi, T., & Casida, J. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070042397 · Cited by 363
CORRELATIONS BETWEEN THE CHEMICAL STRUCTURE AND THE PHARMACOLOGICAL ACTIONS OF THE STEROIDS1
SELYE, H. (1942) · Endocrinology · doi:10.1210/endo-30-3-437 · Cited by 348
GABA-Activated Ligand Gated Ion Channels: Medicinal Chemistry and Molecular Biology
Chebib, M., & Johnston, G. A. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9904349 · Cited by 345
Self-citationPharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla
Avallone, R., Zanoli, P., Puia, G., Kleinschnitz, M., Schreier, P., & Baraldi, M. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00264-1 · Cited by 336
KROGSGAARD-LARSEN, P., JOHNSTON, G. A. R., LODGE, D., & CURTIS, D. R. (1977) · Nature · doi:10.1038/268053a0 · Cited by 335
Self-citationThe influence of subunit composition on the interaction of neurosteroids with GABAA receptors
Belelli, D., Casula, A., Ling, A., & Lambert, J. J. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00172-7 · Cited by 334
GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery?
Whiting, P. J. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02703-x · Cited by 326
Johnston, G. A. R. (1996) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)02043-8 · Cited by 320
Self-citationSedation and Anesthesia Mediated by Distinct GABA A Receptor Isoforms
Reynolds, D. S., Rosahl, T. W., Cirone, J., O'Meara, G. F., Haythornthwaite, A., Newman, R. J., Myers, J., Sur, C., Howell, O., Rutter, A. R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-24-08608.2003 · Cited by 318 · cited 2×
“Furthermore, the recovery of function in the genetically modified mice was considerably improved after etomidate anaesthesia suggesting that β3 selective agents could be used as anaesthetics with significantly improved recovery profile [91].”
BackgroundJones, A., Korpi, E. R., McKernan, R. M., Pelz, R., Nusser, Z., Mäkelä, R., Mellor, J. R., Pollard, S., Bahn, S., Stephenson, F. A., et al. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-04-01350.1997 · Cited by 318
Mechanism of action of the hypnotic zolpidem in vivo
Crestani, F., Martin, J. R., Möhler, H., & Rudolph, U. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703717 · Cited by 307
Medicinal plants and Alzheimer’s disease: From ethnobotany to phytotherapy
Perry, E. K., Pickering, A. T., Wang, W. W., Houghton, P. J., & Perry, N. S. L. (1999) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357991772808 · Cited by 285
A Splice-Site Mutation in GABRG2 Associated With Childhood Absence Epilepsy and Febrile Convulsions
Kananura, C., Haug, K., Sander, T., Runge, U., Gu, W., Hallmann, K., Rebstock, J., Heils, A., & Steinlein, O. K. (2002) · Archives of Neurology · doi:10.1001/archneur.59.7.1137 · Cited by 280
Cholesterol and Alzheimer’s disease: Is there a link?
Simons, M., Keller, P., Dichgans, J., & Schulz, J. B. (2001) · Neurology · doi:10.1212/wnl.57.6.1089 · Cited by 257
Zinc-mediated inhibition of GABAA receptors: discrete binding sites underlie subtype specificity
Hosie, A. M., Dunne, E. L., Harvey, R. J., & Smart, T. G. (2003) · Nature Neuroscience · doi:10.1038/nn1030 · Cited by 256
Generating diversity at GAB Aergic synapses
Cherubini, E. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01724-0 · Cited by 256
Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice
Hosseinzadeh, H., & Parvardeh, S. (2004) · Phytomedicine · doi:10.1078/0944-7113-00376 · Cited by 254
Peng, Z., Hauer, B., Mihalek, R. M., Homanics, G. E., Sieghart, W., Olsen, R. W., & Houser, C. R. (2002) · Journal of Comparative Neurology · doi:10.1002/cne.10210 · Cited by 247
GABA and Schizophrenia: A Review of Basic Science and Clinical Studies
Wassef, A., Baker, J., & Kochan, L. D. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000095349.32154.a5 · Cited by 244
Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms
Walters, R. J., Hadley, S. H., Morris, K. D. W., & Amin, J. (2000) · Nature Neuroscience · doi:10.1038/81800 · Cited by 243
Sedative and sleep-enhancing properties of linarin, a flavonoid-isolated from Valeriana officinalis
Fernández, S., Wasowski, C., Paladini, A. C., & Marder, M. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.12.003 · Cited by 238
Preferential Coassembly of α4 and δ Subunits of the γ-Aminobutyric AcidAReceptor in Rat Thalamus
Sur, C., Farrar, S. J., Kerby, J., Whiting, P. J., Atack, J. R., & McKernan, R. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.110 · Cited by 228
Behavioral characterisation of the flavonoids apigenin and chrysin
Zanoli, P., Avallone, R., & Baraldi, M. (2000) · Fitoterapia · doi:10.1016/s0367-326x(00)00186-6 · Cited by 224
GABA potentiation: a logical pharmacological approach for the treatment of acute ischaemic stroke
Green, A. R., Hainsworth, A. H., & Jackson, D. M. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00233-6 · Cited by 215
Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABAA receptor subtypes
Sanna, E., Busonero, F., Talani, G., Carta, M., Massa, F., Peis, M., Maciocco, E., & Biggio, G. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02191-x · Cited by 208
Kavvadias, D., Sand, P., Youdim, K. A., Qaiser, M. Z., Rice‐Evans, C., Baur, R., Sigel, E., Rausch, W., Riederer, P., & Schreier, P. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705828 · Cited by 206
Glycine and gamma-aminobutyric acid(A) receptor function is enhanced by inhaled drugs of abuse.
Beckstead, M. J., Weiner, J. L., Eger, E. I., Gong, D. H., & Mihic, S. J. (2000) · PubMed · Cited by 195
Adkins, C. E., Pillai, G. V., Kerby, J., Bonnert, T. P., Haldon, C., McKernan, R. M., Gonzalez, J. E., Oades, K., Whiting, P. J., & Simpson, P. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104318200 · Cited by 190
Barbiturate interactions at the human GABAA receptor: dependence on receptor subunit combination
Thompson, S. A., Whiting, P. J., & Wafford, K. A. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15221.x · Cited by 188
Benson, J. A., Löw, K., Keist, R., Mohler, H., & Rudolph, U. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00803-5 · Cited by 184
Salvia lavandulaefolia (Spanish Sage) enhances memory in healthy young volunteers
Tildesley, N. T. J., Kennedy, D. O., Perry, E. K., Ballard, C. G., Savelev, S., Wesnes, K. A., & Scholey, A. B. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00122-9 · Cited by 184
Woodward, R. M., Polenzani, L., & Miledi, R. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13444-5 · Cited by 182
Homanics, G. E., Ferguson, C., Quinlan, J. J., Daggett, J., Snyder, K., Lagenaur, C., Mi, Z.-P., Wang, X.-H., Grayson, D. R., & Firestone, L. L. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.4.588 · Cited by 180
Ebert, B., Wafford, K. A., Whiting, P. J., Krogsgaard-Larsen, P., & Kemp, J. A. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09839-6 · Cited by 177
Potentiation of GABAAReceptors Expressed in Xenopus Oocytes by Perfume and Phytoncid
AOSHIMA, H., & HAMAMOTO, K. (1999) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.63.743 · Cited by 176
Smart, T. G. (1997) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(97)80063-3 · Cited by 175
Defining the Propofol Binding Site Location on the GABAA Receptor
Bali, M., & Akabas, M. H. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.1.68 · Cited by 175
Knoflach, F., Benke, D., Wang, Y., Scheurer, L., Lüddens, H., Hamilton, B. J., Carter, D. B., Mohler, H., & Benson, J. A. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09554-9 · Cited by 174
GABA-A-Receptor Ligands of Flavonoid Structure
Marder, M., & Paladini, A. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026023393462 · Cited by 173
Locatelli, S., Lütjohann, D., Schmidt, H., Otto, C., Beisiegel†, U., & von Bergmann, K. (2002) · Archives of Neurology · doi:10.1001/archneur.59.2.213 · Cited by 168
Identification of a Novel, Selective GABAAα5 Receptor Inverse Agonist Which Enhances Cognition
Chambers, M. S., Atack, J. R., Broughton, H. B., Collinson, N., Cook, S. M., Dawson, G. R., Hobbs, S. C., Marshall, G. R., Maubach, K. A., Pillai, G. V., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020582q · Cited by 157
Faulhaber, J., Steiger, A., & Lancel, M. (1997) · Psychopharmacology · doi:10.1007/s002130050241 · Cited by 155
Hansen, S. L., Sperling, B. B., & Sánchez, C. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.026 · Cited by 146
Campbell, E., Chebib, M., & Johnston, G. A. R. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.07.022 · Cited by 146
Self-citationCarling, R. W., Moore, K. W., Street, L. J., Wild, D., Isted, C., Leeson, P. D., Thomas, S., O'Connor, D. V., McKernan, R. M., Quirk, K., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031020p · Cited by 146
Bianchi, M. T., Song, L., Zhang, H., & Macdonald, R. L. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-13-05321.2002 · Cited by 143
The genetics of human epilepsy
Scheffer, I. E., & Berkovic, S. F. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00194-9 · Cited by 143
Dekermendjian, K., Kahnberg, P., Witt, M., Sterner, O., Nielsen, M., & Liljefors, T. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm991010h · Cited by 142
Activation of GABAA Receptors by Guanidinoacetate: A Novel Pathophysiological Mechanism
Neu, A. D., Neuhoff, H., Trube, G., Fehr, S., Ullrich, K., Roeper, J., & Isbrandt, D. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0547 · Cited by 142
Smith, A. J., Alder, L., Silk, J. D., ADKINS, C. E., Fletcher, A. E., Scales, T. M. E., Kerby, J., Marshall, G. R., Wafford, K. A., McKernan, R. M., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.1108 · Cited by 137
Flavonoid modulation of ionic currents mediated by GABAA and GABAC receptors
Goutman, J. D., Waxemberg, M. D., Doñate-Oliver, F., Pomata, P. E., & Calvo, D. J. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01309-8 · Cited by 131
Anxioselective Compounds Acting at the GABAA Receptor Benzodiazepine Binding Site
Atack, J. R. (2003) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007033482841 · Cited by 128
Initial Human Experience with Ganaxolone, a Neuroactive Steroid with Antiepileptic Activity
Monaghan, E. P., Navalta, L. A., Shum, L., Ashbrook, D. W., & Lee, D. A. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01486.x · Cited by 124
Collins, I., Moyes, C. R., Davey, W. B., Rowley, M., Bromidge, F. A., Quirk, K., Atack, J. R., McKernan, R. M., THOMPSON, S., Wafford, K. A., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0110789 · Cited by 121
Spigelman, I., Li, Z., Liang, J., Cagetti, E., Samzadeh, S., Mihalek, R., Homanics, G. E., & Olsen, R. W. (2003) · Journal of Neurophysiology · doi:10.1152/jn.01022.2002 · Cited by 118
Butterweck, V., Nahrstedt, A., Evans, J., Hufeisen, S., Rauser, L., Savage, J. E., Popadak, B. A., Ernsberger, P. R., & Roth, B. L. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1073-7 · Cited by 116
Terpene Trilactones from Ginkgo biloba Are Antagonists of Cortical Glycine and GABAA Receptors
Ivic, L., Sands, T. T., Fishkin, N. E., Nakanishi, K., Kriegstein, A. R., & Strømgaard, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304034200 · Cited by 114
Dynamic regulation of GABAA receptors at synaptic sites
Kneussel, M. (2002) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00159-5 · Cited by 102
Mohammadi, B., Haeseler, G., Leuwer, M., Dengler, R., Krampfl, K., & Bufler, J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01033-0 · Cited by 99
Korpi, E. R., Koikkalainen, P., Vekovischeva, O. Y., Mäkelä, R., Kleinz, R., Uusi‐Oukari, M., & Wisden, W. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00421.x · Cited by 93
GABAA Receptor Subtype Selective Cognition Enhancers
Maubach, K. A. (2003) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007033482779 · Cited by 89
GABAC Receptors as Drug Targets
Johnston, G. A. R., Chebib, M., Hanrahan, J. R., & Mewett, K. N. (2003) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007033482805 · Cited by 89
Self-citationNielsen, M. B., Frøkjær, S., & Bræstrup, C. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90640-5 · Cited by 85
Natural and synthetic substances related to human health (IUPAC Technical Report)
Topliss, J. G., Clark, A., Ernst, E. K., Hufford, C. D., Johnston, G. A. R., Rimoldi, J. M., & Weimann, B. J. (2002) · Pure and Applied Chemistry · doi:10.1351/pac200274101957 · Cited by 85
Self-citationFunctional characterization of the new human GABAA receptor mutation β3(R192H)
Buhr, A., Bianchi, M. T., Baur, R., Courtet, P., Pignay-Demaria, V., Boulenger, J., Gallati, S., Hinkle, D. J., Macdonald, R. L., & Sigel, E. (2002) · Human Genetics · doi:10.1007/s00439-002-0766-7 · Cited by 83
Huen, M. S. Y., Leung, J. W. C., Ng, W., Lui, W., Chan, M. N. S., Wong, J. T.-F., & Xue, H. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00233-8 · Cited by 83
Huang, S. H., Duke, R. K., Chebib, M., Sasaki, K., Wada, K., & Johnston, G. A. R. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01344-x · Cited by 82
Self-citationPhotoaffinity Labeling with a Neuroactive Steroid Analogue
Darbandi-Tonkabon, R., Hastings, W. R., Zeng, C., Akk, G., Manion, B. D., Bracamontes, J. R., Steinbach, J. H., Mennerick, S. J., Covey, D. F., & Evers, A. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213168200 · Cited by 82
GABA-A Receptor Ligands and their Therapeutic Potentials
Frølund, B., Ebert, B., Kristiansen, U., Liljefors, T., & Krogsgaard‐Larsen, P. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026023393525 · Cited by 82
Kavvadias, D., Monschein, V., Sand, P. G., Riederer, P. F., & Schreier, P. H. (2003) · Planta Medica · doi:10.1055/s-2003-37712 · Cited by 81
GABA receptor function and pharmacology in epilepsy and status epilepticus
Jones, D. M., & MACDONALD, R. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00015-2 · Cited by 77
Halliwell, R. F., Thomas, P., Patten, D., James, C., Martínez‐Torres, A., Miledi, R., & Smart, T. G. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00709.x · Cited by 77
Heterogeneity of Hippocampal GABAAReceptors: Regulation by Corticosterone
Orchinik, M., Carroll, S. S., Li, Y.-H., McEwen, B. S., & Weiland, N. G. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-01-00330.2001 · Cited by 75
3D-QSAR Model of Flavonoids Binding at Benzodiazepine Site in GABAA Receptors
Huang, X., Liu, T., Gu, J., Luo, X., Ji, R., Cao, Y. H., Xue, H., Wong, J. T.-F., Wong, B. L., Pei, G., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000557p · Cited by 75
Antagonist-type interaction of glucocorticoids with the GABA receptor-coupled chloride channel
Majewska, M. D. (1987) · Brain Research · doi:10.1016/0006-8993(87)90107-7 · Cited by 75
Isolation and Identification of "Diazepam-Like" Compounds From Bovine Urine
Luk, K.-C., Stern, L., Weigele, M., et al. (1983) · Journal of Natural Products · doi:10.1021/np50030a005 · Cited by 73
Effects of bilobalide on γ-aminobutyric acid levels and glutamic acid decarboxylase in mouse brain
Sasaki, K., Hatta, S., Haga, M., & Ohshika, H. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00968-6 · Cited by 72
Sooksawate, T., & Simmonds, M. A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704360 · Cited by 72
Chang, H. M., Chui, K. Y., Tan, F. W. L., Yang, Y., Zhong, Z. P., Lee, C. M., Sham, H. L., & Wong, H. Ν. C. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00109a022 · Cited by 69
Effects of Coffee Components on the Response of GABAAReceptors Expressed inXenopusOocytes
Hossain, S. J., Aoshima, H., Kôda, H., & Kiso, Y. (2003) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0303971 · Cited by 69
Critical Review of GABA-ergic Drugs in the Treatment of Schizophrenia
Wassef, A. A., Dott, S. G., Harris, A., Brown, A., O'Boyle, M., Meyer, W. J., & Rose, R. M. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199906000-00004 · Cited by 68
α-Thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization
Deiml, T., Haseneder, R., Zieglgänsberger, W., Rammes, G., Eisensamer, B., Rupprecht, R., & Hapfelmeier, G. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.022 · Cited by 68
Lee, C., Wong, H. Ν. C., Chui, K.-Y., Choang, T. F., Hon, P., & CHANG, H.-M. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90802-z · Cited by 64
Thompson, S. A., Arden, S. A., Marshall, G. R., Wingrove, P. B., Whiting, P. J., & Wafford, K. A. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23248-x · Cited by 64
Naturally occurring 2′-hydroxyl-substituted flavonoids as high-affinity benzodiazepine site ligands
Huen, M. S. Y., Hui, K., Leung, J. W. C., Sigel, E., Baur, R., Wong, J. T.-F., & Xue, H. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.08.016 · Cited by 61
The tyrosine kinase inhibitor genistein directly inhibits GABAA receptors
Huang, R., Fang, M.-J., & Dillon, G. H. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00061-3 · Cited by 61
Study of a GABA c receptor antagonist on sleep-waking behavior in rats
Arnaud, C., Gauthier, P., & Gottesmann, C. (2001) · Psychopharmacology · doi:10.1007/s002130000653 · Cited by 61
Neurosteroids act on the GABAA receptor at sites on the N-terminal side of the middle of TM2
Rick, C., Ye, Q., Finn, S. E., & Harrison, N. L. (1998) · Neuroreport · doi:10.1097/00001756-199802160-00004 · Cited by 60
Feusner, J. D., Ritchie, T. L., Lawford, B. R., Young, R. M., Kann, B., & Noble, E. P. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00296-7 · Cited by 60
Kjær, M., & Nielsen, H. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02203.x · Cited by 59
Holopainen, I. E., Mets�honkala, E.-L., Kokkonen, H., Parkkola, R. K., Manner, T., Någren, K., & Korpi, E. R. (2001) · Annals of Neurology · doi:10.1002/1531-8249(200101)49:1<110::aid-ana17>3.0.co;2-t · Cited by 58
Pistis, M., Belelli, D., McGurk, K. A., Peters, J. A., & Lambert, J. J. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.003ad.x · Cited by 57
THE PHYSIOLOGICAL ACTION OF CHOLESTEROL
Cashin, M. F., & Morávek, V. (1927) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1927.82.2.294 · Cited by 57
Anxiolytic-like action of diazepam: which GABAA receptor subtype is involved?
Reynolds, D. S., McKernan, R. M., & Dawson, G. R. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01773-9 · Cited by 56
Effects of ginsenosides on GABAA receptor channels expressed in xenopus oocytes
Choi, S.-E., Choi, S., Lee, J., Whiting, P. J., Lee, S., & Nah, S.-Y. (2003) · Archives of Pharmacal Research · doi:10.1007/bf03179927 · Cited by 55
Deletion of the GABAA receptor β3 subunit eliminates the hypnotic actions of oleamide in mice
Laposky, A. D., Homanics, G. E., Basile, A. S., & Mendelson, W. B. (2001) · Neuroreport · doi:10.1097/00001756-200112210-00056 · Cited by 55
Loh, E., & Ball, D. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(00)00054-1 · Cited by 55
Rapid neuromodulation by cortisol in the rat paraventricular nucleus: an in vitro study
Zaki, A., & Barrett‐Jolley, R. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704832 · Cited by 55
Salicylidene salicylhydrazide, a selective inhibitor ofβ1‐containing GABAAreceptors
Thompson, S. A., Wheat, L., Brown, N. A., Wingrove, P. B., Pillai, G. V., Whiting, P. J., ADKINS, C. E., Woodward, C. H., Smith, A. J., Simpson, P. B., et al. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705689 · Cited by 53
Chou, I., Peng, C., Huang, C., Tsai, J., Tsai, F., & Tsai, C. (2003) · Pediatric Research · doi:10.1203/01.pdr.0000069696.96041.34 · Cited by 51
Modifying quinolone antibiotics yields new anxiolytics
Johnstone, T. B. C., Hogenkamp, D. J., Coyne, L., Su, J., Halliwell, R. F., Tran, M. B., Yoshimura, R. F., Li, W.-Y., Wang, J., & Gee, K. W. (2003) · Nature Medicine · doi:10.1038/nm967 · Cited by 51
Taylor, M. J., Bhagwagar, Z., Cowen, P. J., & Sharp, T. (2003) · Psychological Medicine · doi:10.1017/s0033291702006876 · Cited by 50
Steroid Modulation of GABAA Receptors
Lambert, J. J., Peters, J. A., Harney, S. C., & Belelli, D. (2001) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-56833-6_4 · Cited by 49
Potentiation of the Ionotropic GABA Receptor Response by Whiskey Fragrance
Hossain, S. J., Aoshima, H., Kôda, H., & Kiso, Y. (2002) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf020448e · Cited by 47
Sinkkonen, S. T., Homanics, G. E., & Korpi, E. R. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00123-x · Cited by 47
Hall, B. J., Chebib, M., Hanrahan, J. R., & Johnston, G. A. R. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.03.014 · Cited by 47
Self-citationQuinlan, J. J., Firestone, L. L., & Homanics, G. E. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00225-2 · Cited by 46
Fisher, J. L. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.11.015 · Cited by 46
Ha, J., Lee, K.-Y., Choi, H.-C., et al. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.128 · Cited by 46
Voss, J., Sánchez, C., Michelsen, S., & Ebert, B. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.10.007 · Cited by 44
GABAB Receptors as Potential Therapeutic Targets
Vacher, C., & Bettler, B. (2003) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007033482814 · Cited by 44
Sigel, E., & Baur, R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742590.x · Cited by 43
Stórustovu, S. Í., & Ebert, B. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01603-0 · Cited by 42
Specific GABAA agonists and partial agonists
Krogsgaard‐Larsen, P., Frølund, B., & Liljefors, T. (2002) · The Chemical Record · doi:10.1002/tcr.10040 · Cited by 42
Sinkkonen, S. T., Mansikkamäki, S., Möykkynen, T. P., Lüddens, H., Uusi‐Oukari, M., & Korpi, E. R. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.3.753 · Cited by 42
Darbandi-Tonkabon, R., Manion, B. D., Hastings, W. R., Craigen, W. J., Akk, G., Bracamontes, J. R., He, Y., Sheiko, T. V., Steinbach, J. H., Mennerick, S. J., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.058123 · Cited by 42
Orchinik, M., Hastings, N. B., Witt, D. M., & McEwen, B. S. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(96)00191-4 · Cited by 41
Krogsgaard‐Larsen, P., Frølund, B., Kristiansen, U., Frydenvang, K., & Ebert, B. (1997) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)10009-4 · Cited by 40
Burt, D. R. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00505-8 · Cited by 39
The Ligand Gated Ion Channel database: an example of a sequence database in neuroscience
Novère, N. L., & Changeux, J. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2001.0903 · Cited by 38
Methodological approaches for the study of GABA A receptor pharmacology and functional responses
Smith, A. J., & Simpson, P. B. (2003) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-003-2172-y · Cited by 37
Cortisol: A potent biphasic modulator at GABAA-receptor complexes in the guinea pig isolated ileum
Ong, J. A., Kerr, D. I. B., & Johnston, G. A. R. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90178-9 · Cited by 37
Self-citationγ-Aminobutyric Acid Type A Receptor β2 Subunit Mediates the Hypothermic Effect of Etomidate in Mice
Cirone, J., Rosahl, T. W., Reynolds, D. S., Newman, R. J., O’Meara, G. F., Hutson, P. H., & Wafford, K. A. (2004) · Anesthesiology · doi:10.1097/00000542-200406000-00016 · Cited by 37
Chatterjee, S. S., Kondratskaya, E., & Krishtal, O. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-40455 · Cited by 36
Tonic benzodiazepine-sensitive GABAergic inhibition in cultured rodent cerebellar granule cells
Leão, R. M., Mellor, J. R., & Randall, A. D. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00177-x · Cited by 36
Inhibition of GABAAReceptor Function by Tyrosine Kinase Inhibitors and Their Inactive Analogues
Dunne, E. L., Moss, S. J., & Smart, T. G. (1998) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1998.0717 · Cited by 34
Rosmond, R., Bouchard, C., & Björntorp, P. A. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802022 · Cited by 34
Wall, M. J. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00085-0 · Cited by 33
Vafa, B., & Schofield, P. R. (1998) · International review of neurobiology · doi:10.1016/s0074-7742(08)60613-3 · Cited by 27
Sasaki, K., Oota, I., Wada, K., Inomata, K., Ohshika, H., & Haga, M. (1999) · Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology · doi:10.1016/s0742-8413(99)00082-1 · Cited by 25
Brochet, D., Chermat, R., DeFeudis, F. V., & Drieu, K. (1999) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(99)00018-x · Cited by 22
Aging of Whiskey Increases the Potentiation of GABAAReceptor Response
Kôda, H., Hossain, S. J., Kiso, Y., & Aoshima, H. (2003) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf030111s · Cited by 19
Mutations linked to generalized epilepsy in humans reduce GABAA receptor current
MACDONALD, R., Bianch, M. T., & Feng, H. (2003) · Experimental Neurology · doi:10.1016/j.expneurol.2003.08.011 · Cited by 17
Kristiansen, U., & Lambert, J. D. C. (1996) · Neuropharmacology · doi:10.1016/s0028-3908(96)00070-6 · Cited by 17
Do Glucocorticoids Have Adverse Effects on Brain Function?
Keenan, P. A., & Kuhn, T. W. (1999) · CNS Drugs · doi:10.2165/00023210-199911040-00001 · Cited by 13
Validation of GABAA Receptor Subtypes as Potential Drug Targets by Using Genetically Modified Mice
Rosahl, T. W. (2003) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007033482823 · Cited by 13
GABA α6 receptors mediate midazolam-induced anxiolysis
Hoffman, W. E., Balyasnikova, I. V., Mahay, H., Danilov, S. M., & Baughman, V. L. (2002) · Journal of Clinical Anesthesia · doi:10.1016/s0952-8180(02)00343-4 · Cited by 11
Cited by
Olsen, R. W., & Sieghart, W. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00505 · Cited by 1,064
The Lipophilic Bullet Hits the Targets: Medicinal Chemistry of Adamantane Derivatives
Wanka, L., Iqbal, K., & Schreiner, P. R. (2013) · Chemical Reviews · doi:10.1021/cr100264t · Cited by 696
Neuroprotective potential of phytochemicals
Kumar, G., & Khanum, F. (2012) · Pharmacognosy Reviews · doi:10.4103/0973-7847.99898 · Cited by 511
Molecular Targets for Antiepileptic Drug Development
Meldrum, B. S., & Rogawski, M. A. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2006.11.010 · Cited by 468
Williams, R. J., & Spencer, J. P. E. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.010 · Cited by 448
Metadata
- Authors
- Johnston, G.
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2005-06-01
- Volume
- 11
- Issue
- 15
- Pages
- 1867-1885
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W1989578288
- Cited by
- 274
- References
- 173
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.